NEWS FEED & ADDITIVE MAGAZINE June 2024 87 Dan Cosgrove named as CAO and General Counsel by Benson Hill Benson Hill, Inc., an ag tech company aiming to unlock the natural genetic diversity of plants, named one of the agriculture industry leaders Dan Cosgrove as Chief Administrative Officer (CAO) and General Counsel. He will assume responsibility for Benson Hill’s day-to-day operations related to business development, compliance, and legal matters. Chief Legal Officer Yevgeny Fundler is leaving Benson Hill to pursue other opportunities, the company revealed. Most recently Cosgrove served as Chief Executive Officer of Growers Edge, a company that offers crop plans, finance solutions, land valuation and software and data analytics tools to agriculture. His previous agriculture work also includes key roles at Corteva Agriscience/ DuPont Pioneer, where he played an important part in the seed company’s global expansion and licensing approach. Drawing on his deep industry knowledge, Benson Hill noted that Cosgrove will oversee all government affairs and administrative functions at Benson Hill to drive strategic initiatives and support the company’s evolution to an asset-light business model. “We are thrilled to welcome such a respected and accomplished agriculture leader to our executive leadership team,” said Deanie Elsner, Chief Executive Officer of Benson Hill. “While business development anchors Dan’s impressive skillset, his global intellectual property and licensing expertise will be pivotal as we pursue value-chain partnerships. His appointment is an important step in our strategy to serve large-scale soy markets through seed innovations that deliver better feed, better food and better fuel.” “We’re grateful to Yevgeny for his contributions to Benson Hill over the past three years,” added Elsner. “He provided essential support during the go-public process, M&A activities, and several business negotiations, and we wish him all the best.” Read more>> Boehringer Ingelheim, one of the global leaders in animal health, celebrated a new and innovative laboratory space at its St. Joseph, Missouri location by hosting a ribbon cutting. The company states that this state-of-the-art facility is set to revolutionize the development of future products, including biotherapeutics. The new laboratory is described as a testament to Boehringer's commitment to innovation and excellence. This late-stage R&D laboratory, the only one of its kind in the US, is designed to streamline the process of transitioning products from development to manufacturing, enhancing the company's ability to serve animals better. The lab's flexible design and proprietary equipment, which allows scientists to mimic operations, removes hurdles of transfers and maximizes efficiency. "As we venture into exciting new areas of innovation, this facility will play a pivotal role and will be instrumental in driving R&D for future products," said Caroline Belmont, Vice President of US Global Innovation at Boehringer Ingelheim. Boehringer's St. Joseph location is a key site within the company's global operations. This location is primarily dedicated to the product development and production of animal health products for livestock and horses. The opening of this new laboratory underscores the company's dedication to leading the industry in vaccine development and manufacturing – and to the community in which it operates. Read more>> Boehringer Ingelheim unveils new R&D laboratory Dan Cosgrove
RkJQdWJsaXNoZXIy MTUxNjkxNQ==